FDA Grants Fast Track Designation to Sucampo's Cobiprostone for Oral Mucositis
07 mai 2015 16h42 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 7, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA)...
Sucampo Reports First Quarter 2015 Financial Results and Corporate Update
06 mai 2015 06h30 HE
|
Sucampo Pharmaceuticals Inc
Strong Financial Performance Driven by Continued Revenue and Sales Growth of AMITIZA
Strong Growth in Net Income and EPS
Company Confirms 2015 Earnings Guidance
Company to Host Conference Call...
Sucampo Announces First Quarter 2015 Earnings Call
22 avr. 2015 06h45 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., April 22, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will host its first quarter 2015...
Sucampo Announces Webcast of Its Presentation at the 14th Annual Needham Healthcare Conference
07 avr. 2015 06h45 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., April 7, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo to Return All Licenses for Unoprostone Isopropyl to R-Tech Ueno
09 mars 2015 02h40 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., March 9, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced it will immediately return all licenses for...
Sucampo Reports Fourth Quarter and Full Year 2014 Financial Results and Corporate Update
04 mars 2015 06h30 HE
|
Sucampo Pharmaceuticals Inc
Strong Year-over-Year Revenue and Sales Growth for AMITIZA
Significant Progress on Pipeline Programs and Strategic Plan
Net Income and EPS Excluding Special Items in Line with 2014 Guidance...
Sucampo Announces Webcast of Its Presentation at the 27th Annual ROTH Conference
03 mars 2015 06h45 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., March 3, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Announces Webcast of Its Presentation at the 2015 Cowen and Company Healthcare Conference
22 févr. 2015 14h30 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Feb. 22, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2014 Earnings Call
18 févr. 2015 06h45 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Feb. 18, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will host its fourth quarter and...
Sucampo Announces Resolution of Par Pharmaceutical's ANDA for RESCULA(R)
11 févr. 2015 16h02 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Feb. 11, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Sucampo and R-Tech Ueno, Ltd. (RTU),...